Dementia-focused mental health company Rippl catapulted out of stealth with $32 million in seed funding.
Why it matters: Rippl couldn't have timed it better if it tried: it debuts one day after an investigational Alzheimer's treatment offered what experts are calling the most encouraging findings to date.
